title: Mucosal antifungal defence: IL-17 signalling takes centre stage.
authors.affiliation: Institute of Medical Microbiology and Hygiene University Hospital, Freiburg, Germany. erik-oliver.glocker@uniklinik-freiburg.de
authors.forename: Erik-Oliver
authors.initials: EO
authors.lastname: Glocker
authors.forename: Bodo
authors.initials: B
authors.lastname: Grimbacher
mesh_terms: D000818:Animals; D053468:CARD Signaling Adaptor Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D002176:Candida albicans / Q000276:immunology / Q000472:pathogenicity; D002178:Candidiasis, Chronic Mucocutaneous / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D018928:Immunity, Mucosal; D016867:Immunocompromised Host; D020381:Interleukin-17 / Q000235:genetics / Q000378:metabolism*; D008264:Macrophages / Q000276:immunology; D051379:Mice; D009092:Mucous Membrane / Q000276:immunology*; D015398:Signal Transduction; D058504:Th17 Cells / Q000276:immunology*
chemical_list: D053468:CARD Signaling Adaptor Proteins; C505855:CARD9 protein, human; D020381:Interleukin-17